Is it time for SABR to overtake surgery as the treatment of choice for stage I non-small cell lung cancer?

ABSTRACT:

SUBMITTER: Love SM 

PROVIDER: S-EPMC5233541 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature